Skip to main content
. Author manuscript; available in PMC: 2015 Feb 15.
Published in final edited form as: Lancet. 2013 Nov 20;383(9917):614–621. doi: 10.1016/S0140-6736(13)62302-8

Table 4.

Adverse events by randomisation assignment

Interventional therapy (n=114)
Medical management (n=109)
p value
Number of events Rate per patient-year Number of events Rate per patient-year
Stroke*
 All 45 0·144 12 0·039 <0·0001
 Haemorrhagic 33 0·106 8 0·026 ··
 Ischaemic 12 0·038 4 0·013 ··

Focal deficit
 All 14 0·045 1 0·003 0·0008
 Persistent 4 0·013 1 0·003 ··
 Reversible 10 0·032 0 0 ··

Seizure
 All 50 0·160 40 0·131 0·34
 Focal (simple, complex) 30 0·096 14 0·045 ··
 Generalised 16 0·051 19 0·062 ··
 Not classified 4 0·013 7 0·023 ··

Headache
 All 65 0·208 59 0·193 0·67
 Migraine (with or without aura) 15 0·048 28 0·091 ··
 Tension-type (episodic, chronic) 30 0·096 29 0·094 ··
Unclassified, other 21 0·067 15 0·049 ··

Contrast reaction 1 0·003 0 0 0·31
Catheter adherence 1 0·003 0 0 0·31
Infection 2 0·003 0 0 0·15

Data are number of events.

*

Including recurrent stroke.

Neurological deficit unrelated to stroke.